Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Injectable GLP-1s: Which Is Right for You
an investigation into N-terminally constrained analogues of glucagon-like peptide 1 (GLP-1) and Exendin-4
For patients with BMIs that started above 35, significant metabolic syndrome, or a history of yo-yo dieting, maintenance dosing often produces the best long-term outcomes
A recent case-control study adds further evidence in the potential carcinogenicity of O
Building on that foundation, this update summarizes the latest research on the role of excitotoxicity in neurodegenerative diseases such as Alzheimers disease, Parkinsons disease, Huntingtons disease, and amyotrophic lateral sclerosis, as well as new cutting-edge techniques applied in the study of excitotoxicity
US$ 24.39
US$ 26.78
US$ 22.36
US$ 23.13
US$ 22.34
US$ 26.79
US$ 28.07
US$ 22.54
US$ 23.13
